Skip to main content

Advertisement

Table 5 Muscle composition and size data divided in three groups according to the assigned intervention

From: Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study

Variables Exercise group Dopamine agonists group Placebo group
EMCL CSA (cm 2 )    
Baseline 13.9±5.1 7.6±2.1 10.0±5.2
6-m post 11.2±5.8 6.8±3.6 9.4±2.0
Δ Change −2.62±5.15 −0.79±3.33 −0.61±3.92
95% CI of Δ Change −5.46 to 0.22 −3.86 to 2.21 −4.23 to 3.01
EMCL (%)    
Baseline 10.9±3.8 8.7±3.6 8.7±3.9
6-m post 8.2±3.5† 7.1±2.7 8.4±1.5
Δ Change −2.70±3.90 −1.65±3.45 −0.21±3.54
95% CI of Δ Change −4.85 to −0.55 −4.83 to 1.53 −3.48 to 3.06
Muscle CSA (cm 2 )    
Baseline 99.5±14.5 82.5±22.5 98.9±7.3
6-m post 106.8±24.4 89.4±24.5 95.8±2.0
Δ Change 7.32±16.03 6.93±17.66 - 3.15±7.87
95% CI of Δ Change 16.18 to −1.54 23.22 to −9.39 −10.42 to 4.12
Muscle (%)    
Baseline 87.9±3.7 85.7±7.2 88.1±3.9
6-m post 88.9±4.5 88.1±5.9 88.2 ±2.2
Δ Change 0.96±5.50 2.39±4.89 0.07±1.64
95% CI of Δ Change 4.00 to −2.04 8.90 to −2.12 1.58 to −1.44
SAT CSA (cm 2 )    
Baseline 142.8±57.8 88.7±46.7 103.6±28.4
6-m post 143.8±64.8 95.5±39.3 99.7±14.9
Δ Change 0.98±18.88 6.80±19.34 −3.95±17.97
95% CI of Δ Change 11.42 to −9.46 24.67 to −11.07 −20.55 to 12.65
  1. All data are mean ± SD. Abbreviations: EMCL Extramyocellular lipids (fat infiltration), CSA Cross sectional area, SAT Subcutaneous adipose tissue.
  2. Significantly different from the respective baseline value.